» Articles » PMID: 2938072

Quinolones and Colonization Resistance in Human Volunteers

Overview
Specialty Pharmacy
Date 1986 Feb 21
PMID 2938072
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The suppression of alimentary canal flora by the three quinolones nalidixic acid, ciprofloxacin and pefloxacin was investigated in fifteen volunteers. They received the three quinolone compounds in tablet form both uncoated and colon-coated. Escherichia coli suppression was poor under nalidixic acid, but complete under ciprofloxacin and pefloxacin for both administration forms. The indigenous anaerobic flora contributing to the control of aerobic Streptococcus faecalis and Candida albicans in the intestines ('colonization resistance') was not affected by nalidixic acid and pefloxacin, and only slightly by ciprofloxacin. Out of the three quinolone compounds, only colon-coated pefloxacin was associated with a considerable absorption rate at colonic level. Using these criteria of successful Escherichia coli clearing from the intestinal canal--left the indigenous flora more or less intact (in a 'selective' way)--and a good absorption rate, pefloxacin is found to be superior to ciprofloxacin and nalidixic acid. These results suggest that a colon-coated tablet with a low dose of pefloxacin is a promising administration form in the therapy of recurrent urinary tract infections and diarrhoeal diseases and in the prevention of gut colonization in immunocompromised hosts.

Citing Articles

Human gut microbiota: repertoire and variations.

Lagier J, Million M, Hugon P, Armougom F, Raoult D Front Cell Infect Microbiol. 2012; 2:136.

PMID: 23130351 PMC: 3487222. DOI: 10.3389/fcimb.2012.00136.


Effect of quinolones on intestinal ecology.

Edlund C, Nord C Drugs. 1999; 58 Suppl 2:65-70.

PMID: 10553709 DOI: 10.2165/00003495-199958002-00013.


Excretion of ciprofloxacin into the large bowel of the rabbit.

Ramon J, Dautrey S, Farinoti R, Carbon C, Rubinstein E Antimicrob Agents Chemother. 1996; 40(1):11-3.

PMID: 8787870 PMC: 163047. DOI: 10.1128/AAC.40.1.11.


Effect of quinolones on the human intestinal microflora.

Nord C Drugs. 1995; 49 Suppl 2:81-5.

PMID: 8549421 DOI: 10.2165/00003495-199500492-00013.


Comparative effects of enoxacin and norfloxacin on human colonic microflora.

Edlund C, Lidbeck A, Kager L, Nord C Antimicrob Agents Chemother. 1987; 31(11):1846-8.

PMID: 3481249 PMC: 175051. DOI: 10.1128/AAC.31.11.1846.


References
1.
Van Der Waaij D . Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Lond). 1971; 69(3):405-11. PMC: 2130899. DOI: 10.1017/s0022172400021653. View

2.
Preiksaitis J, Thompson L, Harding G, Marrie T, Hoban S, Ronald A . A comparison of the efficacy of nalidixic acid and cephalexin in bacteriuric women and their effect on fecal and periurethral carriage of enterobacteriaceae. J Infect Dis. 1981; 143(4):603-8. DOI: 10.1093/infdis/143.4.603. View

3.
Stamey T, Timothy M, Millar M, Mihara G . Recurrent urinary infections in adult women. The role of introital enterobacteria. Calif Med. 1971; 115(1):1-19. PMC: 1517922. View

4.
Ronald A, Harding C, Mathias R, Wong C, Muir P . Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole. Can Med Assoc J. 1975; 112(13 Spec No):13-6. PMC: 1956444. View

5.
Wade J, de Jongh C, Newman K, Crowley J, Wiernik P, Schimpff S . Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid. J Infect Dis. 1983; 147(4):624-34. DOI: 10.1093/infdis/147.4.624. View